New Drug Approvals Fall to Six-Year Low in 2016

Source: The New York Times

Tuesday, January 03, 2017 | FDA Approval/Clearance , Medical Studies


Last year turned out to be a disappointing one for new drug approvals with the U.S. Food and Drug Administration clearing just 22 new medicines for sale, the lowest number since 2010 and sharply down on 2015's tally of 45. Across the Atlantic, the European Medicines Agency recommended 81 new prescription products against a 2015 total of 93. Unlike the FDA, the EMA includes generic drugs in its list.

Open in New Window

Comments

You must be logged in to leave a comment.